With only 70 months left to meet the SDGs, the world faces a stark reality in the fight against AIDS, requiring urgent action ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...

A yearly injection such as Lenacapavir could help overcome barriers to PrEP accessibility by increasing its uptake and making ...

HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.

As many as 600,000 people could die over the next 10 years in South Africa alone as a result of U.S. funding cuts, study says ...

2024 — A new study reveals significant progress in the global fight against HIV/AIDS, alongside a stark warning that current trends indicate the world is not on track to meet the ambitious ...

Camp Dreamcatcher in Chester County, launched at the height of ‘90s stigma around HIV, has served thousands of children ...

Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...

A low-income housing cooperative for people with HIV and AIDS is fighting to stay open in San Francisco. On Sunday afternoon, ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

Hundreds of HIV doctors and researchers have called on the Trump administration to reverse its sweeping aid funding cuts, saying they are "doing catastrophic harm" to the global fight against AIDS.